These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29649249)

  • 1. Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.
    Tolley EE; Guthrie KM; Zissette S; Fava JL; Gill K; Louw CE; Kotze P; Reddy K; MacQueen K
    PLoS One; 2018; 13(4):e0195499. PubMed ID: 29649249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use.
    Tolley EE; Zissette S; Martinez A; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2020; 15(12):e0242881. PubMed ID: 33351805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
    Zissette S; Tolley EE; Martinez A; Hanif H; Gill K; Mugo N; Myers L; Casmir E; Duyver M; Ngure K; Doncel GF
    PLoS One; 2021; 16(5):e0251823. PubMed ID: 34043657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings.
    MacQueen KM; Tolley EE; Owen DH; Amico KR; Morrow KM; Moench T; Friend DR; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19158. PubMed ID: 25224617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.
    Montgomery ET; Mensch B; Musara P; Hartmann M; Woeber K; Etima J; van der Straten A
    AIDS Behav; 2017 Feb; 21(2):481-491. PubMed ID: 27858268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings.
    Stalter RM; Moench TR; MacQueen KM; Tolley EE; Owen DH;
    J Int AIDS Soc; 2016; 19(1):20746. PubMed ID: 27142091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a New Three-Item Self-Report Measure for Medication Adherence.
    Wilson IB; Lee Y; Michaud J; Fowler FJ; Rogers WH
    AIDS Behav; 2016 Nov; 20(11):2700-2708. PubMed ID: 27098408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.
    Mensch BS; Richardson BA; Husnik M; Brown ER; Kiweewa FM; Mayo AJ; Baeten JM; Palanee-Phillips T; van der Straten A;
    AIDS Behav; 2019 Feb; 23(2):504-512. PubMed ID: 30218318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK; Mensch BS; Woeber K; Musara P; Etima J; van der Straten A
    BMC Womens Health; 2019 Jan; 19(1):18. PubMed ID: 30683103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
    Palanee-Phillips T; Roberts ST; Reddy K; Govender V; Naidoo L; Siva S; Gafoor Z; Pather A; Matovu F; Hlahla K; Makanani B; Nair G; Schwartz K; Torjesen K; Brown E; Soto-Torres L; Baeten J; Montgomery ET
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):580-589. PubMed ID: 30239426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV.
    Kutner BA; Giguere R; Lentz C; Kajura-Manyindo C; Dolezal C; Butheliezi S; Gwande M; Nampiira S; Ndlovu T; Mvinjelwa P; Mwenda W; Balán IC
    AIDS Behav; 2021 Mar; 25(3):721-731. PubMed ID: 32920652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?
    Mensch BS; Brown ER; Liu K; Marrazzo J; Chirenje ZM; Gomez K; Piper J; Patterson K; van der Straten A
    AIDS Behav; 2016 Nov; 20(11):2654-2661. PubMed ID: 26906023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease.
    McHorney CA
    Curr Med Res Opin; 2009 Jan; 25(1):215-38. PubMed ID: 19210154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of a single-item rating scale to monitor medication adherence for people living with HIV and lower health literacy.
    Pellowski JA; Kalichman SC; Finitsis DJ
    HIV Clin Trials; 2015; 16(1):1-9. PubMed ID: 25777184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.
    Amico KR
    Curr Opin HIV AIDS; 2012 Nov; 7(6):542-8. PubMed ID: 22964887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP".
    Mayer KH; Safren SA; Elsesser SA; Psaros C; Tinsley JP; Marzinke M; Clarke W; Hendrix C; Wade Taylor S; Haberer J; Mimiaga MJ
    AIDS Behav; 2017 May; 21(5):1350-1360. PubMed ID: 27848089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.
    Dai JY; Hendrix CW; Richardson BA; Kelly C; Marzinke M; Chirenje ZM; Marrazzo JM; Brown ER
    J Infect Dis; 2016 Feb; 213(3):335-42. PubMed ID: 26123563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and psychometric evaluation of a novel tool for assessing patient perception and preference for haemophilia treatment (HaemoPREF).
    Teal S; Brohan E; Hettema Y; Humphrey L; Willgoss T; Hudgens S; Westfeld M; Cappelleri JC
    Haemophilia; 2014 Sep; 20(5):666-73. PubMed ID: 24720617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension.
    Ma C; Chen S; You L; Luo Z; Xing C
    J Adv Nurs; 2012 Jun; 68(6):1402-13. PubMed ID: 21954893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Psychometric Testing of the Turkish-Version Oral Chemotherapy Adherence Scale.
    Bagcivan G; Akbayrak N
    J Nurs Res; 2015 Dec; 23(4):243-51. PubMed ID: 26562455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.